English
Albanian
Arabic
Armenian
Azerbaijani
Belarusian
Bengali
Bosnian
Catalan
Czech
Danish
Deutsch
Dutch
English
Estonian
Finnish
Français
Greek
Haitian Creole
Hebrew
Hindi
Hungarian
Icelandic
Indonesian
Irish
Italian
Japanese
Korean
Latvian
Lithuanian
Macedonian
Mongolian
Norwegian
Persian
Polish
Portuguese
Romanian
Russian
Serbian
Slovak
Slovenian
Spanish
Swahili
Swedish
Turkish
Ukrainian
Vietnamese
Български
中文(简体)
中文(繁體)
disaccharide/inflammation
The link is saved to the clipboard
15 results
Treatment of inflammatory conditions with hyaluronan disaccharide
Only registered users can translate articles
Log In/Sign up
FIELD OF THE INVENTION
The present invention generally relates to the prevention and treatment of inflammatory conditions and infections.
BACKGROUND
The following description includes information that may be useful in understanding the present invention. It is not an admission that any of the
Administration of valienamine-related disaccharide compounds in reducing inflammation in a sensitized mammal arising from exposure to an antigen
Only registered users can translate articles
Log In/Sign up
BACKGROUND OF THE INVENTION
1. Field of the Invention
The present invention is directed, in part, to the discovery that valienamine-related disaccharide compounds reduce, in vivo, the degree of inflammation arising from a secondary immune response in a mammal due to antigen exposure
Administration of valienamine-related disaccharide compounds in reducing inflammation in a sensitized mammal arising from exposure to an antigen
Only registered users can translate articles
Log In/Sign up
BACKGROUND OF THE INVENTION
1. Field of the Invention
The present invention is directed, in part, to the discovery that valienamine-related disaccharide compounds reduce, in vivo, the degree of inflammation arising from a secondary immune response in a mammal due to antigen exposure
Disaccharide inflammation inhibitors and uses thereof
Only registered users can translate articles
Log In/Sign up
BACKGROUND OF THE INVENTION
1. Field of the Invention
The present invention relates generally to the fields of inflammation and carbohydrate and glycoprotein chemistry. More specifically, the present invention relates to novel disaccharide inhibitors of inflammation.
2. Description of the Related
Hypersulfated disaccharides and methods of using the same for the treatment of inflammations
Only registered users can translate articles
Log In/Sign up
BACKGROUND OF THE INVENTION
1. Field of the Invention
The invention relates to compounds, pharmaceutical compositions, and methods for treating or alleviating the symptoms of inflammation such as, for example, asthma.
2. Summary of the Related Art
Inflammation is a multi-focal host response to
Galactosylated pro-drugs of non-steroidal anti-inflammatories with improved pharmacokinetic characteristics and reduced toxicity of the starting drug
Only registered users can translate articles
Log In/Sign up
The present invention relates to galactosylated pro-drugs of non-steroidal anti-inflammatories with free acid function and the process of synthesis thereof, which enables minimization of the gastrointestinal toxicity of the starting anti-inflammatory by means of esterification of its carboxylic
Low polydispersity, low molecular weight biotechnological chondroitin sulfate with anti-inflammatory and antiarthritis activity and use thereof in the prevention of osteoarthritis
Only registered users can translate articles
Log In/Sign up
TECHNICAL FIELD
The present invention relates to a chondroitin sulfate (CS) with an extremely low and narrowly distributed molecular weight (1000-5000 daltons, polydispersity ranging from 1.1 to 1.3) produced by chemical sulfation of an unsulfated chondroitin backbone obtained with biotechnology
Method of treating inflammatory, tissue repair and infectious conditions
Only registered users can translate articles
Log In/Sign up
Growth factors comprise a family of polypeptides with a manyfold of properties regulating for example cell proliferation and cell metabolism. As being multi-functional molecules, they may stimulate or inhibit cell proliferation as well as affect cell function depending on the type of the target
Method for preparing hydro/organo gelators from disaccharide sugars by biocatalysis and their use in enzyme-triggered drug delivery
Only registered users can translate articles
Log In/Sign up
BACKGROUND OF THE INVENTION
1. Field of the Invention
The present invention relates to hydro/organo gelators, and more particularly, the present invention relates to a method for preparing hydro/organo gelators from disaccharide sugars by biocatalysis and their use in enzyme-triggered drug delivery,
Method for preparing hydro/organo gelators from disaccharide sugars by biocatalysis and their use in enzyme-triggered drug delivery
Only registered users can translate articles
Log In/Sign up
BACKGROUND OF THE INVENTION
Field of the Invention
The present invention relates to hydro/organo gelators, and more particularly, the present invention relates to a method for preparing hydro/organo gelators from disaccharide sugars by biocatalysis and their use in enzyme-triggered drug delivery,
Disaccharides with anti-arthrosic properties
Only registered users can translate articles
Log In/Sign up
The present invention relates to novel disaccharides, the solvates and pharmaceutically acceptable salts thereof, and to the pharmaceutical compositions containing them. This invention also refers to a process for preparing the novel disaccharides, as well as to the therapeutical use thereof.
STATE
Disaccharide ligands for selectins
Only registered users can translate articles
Log In/Sign up
This is the U.S. national stage entry under 35 U.S.C. .sctn. 371 of PCT/GB94/00088, filed Jan. 19, 1994.
FIELD OF THE INVENTION
This invention relates to a series of carbohydrate-based compounds which are useful as anti-inflammatory agents and as agents for the control of tumour metastasis, to the
Keratan sulfate oligosaccharide fraction and pharmaceutical containing the same
Only registered users can translate articles
Log In/Sign up
TECHNICAL FIELD
The present invention relates to an anti-inflammatory agent, antiallergic agent, immunomodulator, cell differentiation inducer, apoptosis inducer, and a keratan sulfate oligosaccharide which is useful as an active ingredient of these pharmaceuticals.
BACKGROUND ART
Keratan sulfate is
Keratan sulfate oligosaccharide fraction and pharmaceutical containing the same
Only registered users can translate articles
Log In/Sign up
TECHNICAL FIELD
The present invention relates to an anti-inflammatory agent, antiallergic agent, immunomodulator, cell differentiation inducer, apoptosis inducer, and a keratan sulfate oligosaccharide which is useful as an active ingredient of these pharmaceuticals.
BACKGROUND ART
Keratan sulfate is
Method of treating angiogenesis
Only registered users can translate articles
Log In/Sign up
Growth factors comprise a family of polypeptides with a manyfold of properties regulating for example cell proliferation and cell metabolism. As being multi-functional molecules, they may stimulate or inhibit cell proliferation as well as affect cell function depending on the type of the target
The most complete medicinal herbs database backed by science
- Works in 55 languages
- Herbal cures backed by science
- Herbs recognition by image
- Interactive GPS map - tag herbs on location (coming soon)
- Read scientific publications related to your search
- Search medicinal herbs by their effects
- Organize your interests and stay up do date with the news research, clinical trials and patents
Type a symptom or a disease and read about herbs that might help, type a herb and see diseases and symptoms it is used against.
*All information is based on published scientific research
